Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

News

Is a long commute a reason to quit?

Published

5 months ago

on

Workers reconsider roles due to lengthy travel times

A surge in resignations is hitting the job market as employees reevaluate the impact of long commutes on their work-life balance. The trend, intensified by the rise of remote work during the pandemic, sees a growing number of professionals opting to quit rather than endure extended travel times.

A recent survey conducted among commuters revealed that 68% of participants identified their daily journeys as a major source of stress. The findings suggest a paradigm shift in the traditional understanding of commuting as an inherent aspect of employment.

Employers are now grappling with the challenge of retaining talent as dissatisfaction with lengthy commutes becomes a catalyst for resignations. The implications extend beyond individual decisions, impacting productivity and overall workforce dynamics.

The phenomenon underscores the need for businesses to reassess their remote work policies and invest in solutions that alleviate the burden of commuting. As the job market adapts to evolving expectations, companies that fail to address the commute conundrum risk losing valuable contributors.

Related Topics:
Continue Reading

News

European elections loom: the rise of the far-right

Published

15 hours ago

on

May 15, 2024

By

What can we expect from the upcoming European elections?

Euro Bloch is a comprehensive program designed to highlight the breadth of topics and issues within the EU political landscape. It offers insightful analysis within the evolving framework of relations between the European Union and Australia/Asia-Pacific region. Hosted by Natanael Bloch.

Next month’s EU elections are looming, with the far-right gaining traction. In this episode, Natanael is joined by Professor Bruce Wilson, Director of EU Centre of Excellence at RMIT University. #EURO BLOCH

Continue Reading

News

Will the U.S. approve MDMA therapy?

Published

23 hours ago

on

May 15, 2024

By

MDMA is a drug commonly known as molly or ecstasy.

Some medical professionals say it can be helpful for people with post-traumatic stress disorder — which is why a group has been fighting to get MDMA legalized as a prescription drug.

Currently, the U.S. Food and Drug Administration is reviewing an application to use MDMA to treat PTSD. The agency is expected to announce its ruling as soon as August.

Anna Silman, a features correspondent with Business Insider joins Veronica Dudo to discuss. #IN AMERICA TODAY #trending #drugs #MDMA #MDMATherapy #business #pharmaceutical

Continue Reading

News

Apple responds to crushing iPad Pro criticism

Published

1 day ago

on

May 14, 2024

By

Apple issued an apology following backlash over a recent advertisement for the latest iPad Pro.

On this episode of Ahron & Mike Live – Painted Panda dogs confuse zoo goers, luxury Police cars cruise the roads, Siri meets up with ChatGpt and Apple’s “Crush” iPad ad faces overwhelming backlash.

Ticker’s Ahron Young & Mike Loder discuss. #featured #trending

Continue Reading

Trending Now